IFNA1 and COVID-19: Older age, male sex, chronic lung and cardiovascular diseases, diabetes mellitus, obesity, host genetics, and IFN autoantibodies have also been associated with severe disease and death8–11, but these factors alone do not appear to explain the wide variability in the clinical course of COVID-19.